Zepteon, Inc. is a privately held corporation founded in 2012 that has developed first in class chromatography resins capable of separating antibodies with specific sugar structures (nonfucosylated) that are more potent against diseases like cancer. This technology enables more effective therapeutics and can reduce cost and dosing requirements.

Biotechnology

Zepteon

Austin W. Boesch

Glen R. Bolton

Zepteon's Founding Team includes Austin W. Boesch and 1 others.

Founding Team

About

Team members

Other teams at Zepteon

Board of Directors

CEO and Executive Team